pubmed.ncbi.nlm.nih.gov

Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome - PubMed

Randomized Controlled Trial

Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome

Aletta E Schutte et al. Am J Hypertens. 2006 Jun.

Abstract

Background: Impaired baroreflex sensitivity (BRS) is associated with cardiovascular diseases and the metabolic syndrome. Because lipid abnormalities have been associated with impaired BRS, this study aimed to determine whether diets known to improve the lipid profile, namely a diet high in polyunsaturated fatty acids (walnuts) or monounsaturated fatty acids (cashew nuts), would improve BRS in subjects with metabolic syndrome (MS).

Methods: A controlled feeding trial with a randomized, controlled, parallel study design was undertaken, which involved 62 subjects with MS. Subjects were stratified according to gender and age and were randomized into three groups receiving a control diet, or a diet high (20% energy) in walnuts or unsalted cashew nuts for 8 weeks while maintaining body weight. The BRS, C-reactive protein (CRP), and MS components were measured before and after the intervention.

Results: After the intervention, BRS in the walnut-fed study group decreased (P = .038) and that in the cashew-fed study group increased (P = .036), but the BRS in the control group did not change (P = .56). The percent change of the walnut versus cashew group differed (P = .019). Body mass index, waist circumference, blood pressure, high-density lipoprotein cholesterol, and triacylglycerol did not change. The fasting glucose concentrations of the cashew group increased (P = .03).

Conclusions: The significant improvements in BRS obtained by a diet rich in cashew nuts underline the beneficial cardiovascular effects of nuts. However, the opposite result was obtained with a diet rich in walnuts. These significant changes observed might indicate that BRS is particularly sensitive and influenced by changes in diet without changes in obesity.

PubMed Disclaimer

Comment in

High dietary nut intake: too much of a good thing?
Laaksonen DE. Laaksonen DE. Am J Hypertens. 2006 Jun;19(6):637-8. doi: 10.1016/j.amjhyper.2006.02.008. Am J Hypertens. 2006. PMID: 16733238 Review. No abstract available.

Cited by

Does Nut Consumption Reduce Mortality and/or Risk of Cardiometabolic Disease? An Updated Review Based on Meta-Analyses.
Kim Y, Keogh JB, Clifton PM. Kim Y, et al. Int J Environ Res Public Health. 2019 Dec 6;16(24):4957. doi: 10.3390/ijerph16244957. Int J Environ Res Public Health. 2019. PMID: 31817639 Free PMC article. Review.
Cashew nuts (Anacardium occidentale L.) decrease visceral fat, yet augment glucose in dyslipidemic rats.
Dias CCQ, Madruga MS, Pintado MME, Almeida GHO, Alves APV, Dantas FA, Bezerra JKG, de Melo MFFT, Viera VB, Soares JKB. Dias CCQ, et al. PLoS One. 2019 Dec 12;14(12):e0225736. doi: 10.1371/journal.pone.0225736. eCollection 2019. PLoS One. 2019. PMID: 31830056 Free PMC article.
Nut consumption for the primary prevention of cardiovascular disease.
Martin N, Germanò R, Hartley L, Adler AJ, Rees K. Martin N, et al. Cochrane Database Syst Rev. 2015 Sep 28;2015(9):CD011583. doi: 10.1002/14651858.CD011583.pub2. Cochrane Database Syst Rev. 2015. PMID: 26411417 Free PMC article. Review.
Nuts and Cardio-Metabolic Disease: A Review of Meta-Analyses.
Kim Y, Keogh J, Clifton PM. Kim Y, et al. Nutrients. 2018 Dec 6;10(12):1935. doi: 10.3390/nu10121935. Nutrients. 2018. PMID: 30563231 Free PMC article. Review.
The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Alshahrani SM, Mashat RM, Almutairi D, Mathkour A, Alqahtani SS, Alasmari A, Alzahrani AH, Ayed R, Asiri MY, Elsherif A, Alsabaani A. Alshahrani SM, et al. Nutrients. 2022 Oct 23;14(21):4460. doi: 10.3390/nu14214460. Nutrients. 2022. PMID: 36364723 Free PMC article. Review.

Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome - PubMed